JP2022507776A5 - - Google Patents

Info

Publication number
JP2022507776A5
JP2022507776A5 JP2021527829A JP2021527829A JP2022507776A5 JP 2022507776 A5 JP2022507776 A5 JP 2022507776A5 JP 2021527829 A JP2021527829 A JP 2021527829A JP 2021527829 A JP2021527829 A JP 2021527829A JP 2022507776 A5 JP2022507776 A5 JP 2022507776A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
group
formula
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021527829A
Other languages
English (en)
Japanese (ja)
Other versions
JP7551610B2 (ja
JP2022507776A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/062030 external-priority patent/WO2020106627A1/en
Publication of JP2022507776A publication Critical patent/JP2022507776A/ja
Publication of JP2022507776A5 publication Critical patent/JP2022507776A5/ja
Priority to JP2024152316A priority Critical patent/JP2025000636A/ja
Application granted granted Critical
Publication of JP7551610B2 publication Critical patent/JP7551610B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021527829A 2018-11-19 2019-11-18 C10-アルキレン置換された13員マクロライド及びそれらの使用 Active JP7551610B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024152316A JP2025000636A (ja) 2018-11-19 2024-09-04 C10-アルキレン置換された13員マクロライド及びそれらの使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862769383P 2018-11-19 2018-11-19
US62/769,383 2018-11-19
PCT/US2019/062030 WO2020106627A1 (en) 2018-11-19 2019-11-18 C10-alkylene substituted 13-membered macrolides and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024152316A Division JP2025000636A (ja) 2018-11-19 2024-09-04 C10-アルキレン置換された13員マクロライド及びそれらの使用

Publications (3)

Publication Number Publication Date
JP2022507776A JP2022507776A (ja) 2022-01-18
JP2022507776A5 true JP2022507776A5 (cg-RX-API-DMAC10.html) 2022-11-29
JP7551610B2 JP7551610B2 (ja) 2024-09-17

Family

ID=68916562

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021527829A Active JP7551610B2 (ja) 2018-11-19 2019-11-18 C10-アルキレン置換された13員マクロライド及びそれらの使用
JP2024152316A Pending JP2025000636A (ja) 2018-11-19 2024-09-04 C10-アルキレン置換された13員マクロライド及びそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024152316A Pending JP2025000636A (ja) 2018-11-19 2024-09-04 C10-アルキレン置換された13員マクロライド及びそれらの使用

Country Status (22)

Country Link
US (1) US12552825B2 (cg-RX-API-DMAC10.html)
EP (2) EP4737470A3 (cg-RX-API-DMAC10.html)
JP (2) JP7551610B2 (cg-RX-API-DMAC10.html)
KR (1) KR102929869B1 (cg-RX-API-DMAC10.html)
CN (1) CN113573779A (cg-RX-API-DMAC10.html)
AU (1) AU2019385333B2 (cg-RX-API-DMAC10.html)
BR (1) BR112021009624A2 (cg-RX-API-DMAC10.html)
CA (1) CA3120148A1 (cg-RX-API-DMAC10.html)
DK (1) DK3883647T3 (cg-RX-API-DMAC10.html)
ES (1) ES3063764T3 (cg-RX-API-DMAC10.html)
FI (1) FI3883647T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20260395T1 (cg-RX-API-DMAC10.html)
IL (1) IL283194B2 (cg-RX-API-DMAC10.html)
LT (1) LT3883647T (cg-RX-API-DMAC10.html)
MX (1) MX2021005423A (cg-RX-API-DMAC10.html)
PL (1) PL3883647T3 (cg-RX-API-DMAC10.html)
PT (1) PT3883647T (cg-RX-API-DMAC10.html)
RS (1) RS68104B1 (cg-RX-API-DMAC10.html)
SG (1) SG11202105227QA (cg-RX-API-DMAC10.html)
SI (1) SI3883647T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202600094T1 (cg-RX-API-DMAC10.html)
WO (1) WO2020106627A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202313065A (zh) * 2021-05-28 2023-04-01 美商季卡尼醫療公司 用於治療遺傳疾病之化合物
WO2023250513A1 (en) * 2022-06-24 2023-12-28 Zikani Therapeutics, Inc. 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
JP2025530776A (ja) 2022-09-01 2025-09-17 ジカニ セラピューティクス, インコーポレイテッド 13員環マクロライドを使用した家族性大腸腺腫症の処置

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
NZ526120A (en) * 1999-11-09 2005-02-25 Pfizer Prod Inc 13-membered azalides and their use as antibiotic agents
JP2004516233A (ja) * 2000-04-27 2004-06-03 ファイザー・プロダクツ・インク 哺乳動物の細菌若しくは原生動物感染症を治療するか又は予防するためのアザライド抗生組成物の使用
JP4311203B2 (ja) * 2001-08-08 2009-08-12 大正製薬株式会社 11a−アザライド化合物及びその製造方法
HRP20030381B1 (en) * 2003-05-14 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
RU2008106915A (ru) * 2005-07-26 2009-09-10 Меркле Гмбх (De) Макролидные конъюгаты пирролиновых и индолизиновых соединений
WO2007091393A1 (ja) * 2006-02-07 2007-08-16 Taisho Pharmaceutical Co., Ltd. 10a-アザライド化合物
EP2588084B1 (en) * 2010-07-01 2023-11-22 Elanco Tiergesundheit AG Antibiotic compositions comprising tulathromycin
CN102993250B (zh) * 2011-07-06 2016-02-10 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
EP4095146A1 (en) 2013-04-04 2022-11-30 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
JP2017531663A (ja) 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ 14員ケトライドならびにそれらの調製および使用の方法
WO2016154591A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof
EP3277701A4 (en) 2015-03-25 2019-03-06 President and Fellows of Harvard College SYNTHESIS OF DESOSAMINES
CA3000709A1 (en) * 2015-10-01 2017-04-06 Memorial Sloan-Kettering Cancer Center Inhibitors of menaquinone biosynthesis
US11673910B2 (en) * 2017-04-28 2023-06-13 Zikani Therapeutics, Inc. Macrolides with modified desosamine sugars and uses thereof

Similar Documents

Publication Publication Date Title
CA2876690C (en) Dihydropyrimidine compounds and their application in pharmaceuticals
ES2967453T3 (es) Compuestos de pirrolizina sustituidos y usos de los mismos
EP2943481B1 (en) (hetero)arylacetamide derivatives as antiretroviral agents
JP2021534124A5 (cg-RX-API-DMAC10.html)
RU2626979C2 (ru) Трициклические ингибиторы гиразы
KR20190042667A (ko) 테트라사이클린 화합물 및 치료 방법
BG93979A (bg) Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им
RS66126B1 (sr) Makrociklična jedinjenja kao agonisti uboda i njihove metode i upotreba
JO3271B1 (ar) مشتقات الكوينولين المضادة للجراثيم
NZ603896A (en) 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatement of alzheimer's disease and other forms of dementia
JP2009535307A5 (cg-RX-API-DMAC10.html)
NZ590126A (en) Compounds having antiviral properties
CA2831421A1 (en) Novel cephalosporin derivatives and pharmaceutical compositions thereof
JP2009538910A5 (cg-RX-API-DMAC10.html)
US10144761B2 (en) Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis
CA2463544A1 (en) Cross-linked glycopeptide-cephalosporin antibiotics
TW452579B (en) Antibacterial compounds
JO2684B1 (en) Quinoline antibacterial derivatives
WO2023125825A1 (en) Anticoronviral compounds and compositions and uses thereof
JP2022507795A5 (cg-RX-API-DMAC10.html)
US20240132480A1 (en) Inhibitors of mycobacterium tuberculosis lipoamide dehydrogenase
MX2026002570A (es) Compuestos de oxoisoindolinil piperidin-2,6-diona sustituida
IN2014MN02364A (cg-RX-API-DMAC10.html)
JO2725B1 (en) Quinoline antibacterial derivatives
WO2003082864A3 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them